Recent

% | $
Quotes you view appear here for quick access.

Galena Biopharma, Inc. Message Board

  • hbrotha13 hbrotha13 Dec 30, 2013 3:09 PM Flag

    ABSTRAL CONSERVATIVE ESTIMATE = NO FURTHER DILUTION

    There will be no further dilution. That is a FACT unless Mark Ahn was blatantly lying.
    At the last CC (Oppenheimer, 12/4), Mark Ahn was clear as day that they had already surpassed 5% market share for Abstral sales. If we assume a 500 million dollar market for fentanyl, that would be an annual rate of 20 million dollars. The quarterly rate would be 5 million.

    The last published burn rate was 1.25 million/month. We can say 4 million a quarter, again conservatively.

    Therefore, we have already, at a BARE MINIMUM dealt with our burn rate and will no longer require further dilution.
    Anything greater than 5% is net revenue and the company, independent of neuvax, REAL monitized value.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
GALE
0.4537-0.0089(-1.92%)2:30 PMEDT